PECM regimen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PECM regimen, covering 2017-10-26 to 2017-10-26. Get the full timeline:
Most recent: Clinical Trial Update: Chidamide Combined With PECM in Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) [Phase 2]